Please assess the completion status of the following clinical trial:

Trial Title: Fractional Laser Assisted Topical Anesthesia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with acne scars or traumatic scars scheduled for treatment with the fractional carbon dioxide laser~* Age ≥18 years~* Patient is willing and able to give written informed consent~Exclusion Criteria:~* Known allergy to local anesthesia~* Pregnancy or lactation~* Incompetency to understand what the procedure involves~* Current complaints of chronic pain or other alterations in pain sensation (e.g. due to diabetes mellitus or lepra)~* Current treatment with systemic analgesics or other medication that can influence pain sensation~* Total lesional area to be treated in one session \>600 cm2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Region 1 (Type: ACTIVE_COMPARATOR): Standard topical anesthesia using eutectic mixture of lidocaine 25 mg/g and prilocaine 25 mg/g cream (EMLA cream) applied two hours before treatment.
- Region 2 (Type: EXPERIMENTAL): Anesthesia using articaine hydrochloride 40 mg/ml and epinephrine 10 µg/ml solution (AHES) applied on ablative fractional laser (AFXL) pretreated skin 15 minutes prior to the treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).